{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:57Z","timestamp":1793371017650,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2026.08.105","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:57:41Z","timestamp":1788278261000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Randomized controlled study of nemolizumab in patients with chronic kidney disease-associated pruritus: NIKAIA-1"],"prefix":"10.1016","author":[{"given":"Vandana S.","family":"Mathur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fishbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German T.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Piketty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.08.105_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100900","article-title":"Chronic kidney disease-associated pruritus burden: a patient survey study","volume":"6","author":"Thompson","year":"2024","journal-title":"Kidney Med"},{"key":"10.1016\/j.jaad.2026.08.105_bib2","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2300227","article-title":"Chronic kidney disease-associated pruritus, still a vexing problem","volume":"2","author":"Yosipovitch","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jaad.2026.08.105_bib3","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","article-title":"Pruritus in haemodialysis patients: international results from the dialysis outcomes and practice patterns study (DOPPS)","volume":"21","author":"Pisoni","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaad.2026.08.105_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/hdi.12158","article-title":"Pruritus in hemodialysis patients: results from the Japanese dialysis outcomes and practice patterns study (JDOPPS)","volume":"18","author":"Kimata","year":"2014","journal-title":"Hemodial Int"},{"key":"10.1016\/j.jaad.2026.08.105_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241088","article-title":"Uremic pruritus and long-term morbidities in the dialysis population","volume":"15","author":"Ting","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2026.08.105_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/ckj\/sfz192","article-title":"Routinely measuring symptom burden and health-related quality of life in dialysis patients: first results from the dutch registry of patient-reported outcome measures","volume":"14","author":"van der Willik","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jaad.2026.08.105_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaad.2020.08.059","article-title":"Sleep disturbance in adults with chronic pruritic dermatoses is associated with increased C-reactive protein levels","volume":"84","author":"Patel","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.105_bib8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1159\/000490689","article-title":"Uremic pruritus is associated with two-year cardiovascular mortality in long term hemodialysis patients","volume":"43","author":"Weng","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jaad.2026.08.105_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","article-title":"Treatment of uremic pruritus: a systematic review","volume":"70","author":"Simonsen","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaad.2026.08.105_bib10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2215\/CJN.01610214","article-title":"Setting research priorities for patients on or nearing dialysis","volume":"9","author":"Manns","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2026.08.105_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2147\/CCID.S289716","article-title":"Current clinical options for the management of itch in atopic dermatitis","volume":"14","author":"Lipman","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jaad.2026.08.105_bib12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaad.2020.06.991","article-title":"Clinically meaningful change in itch intensity scores: an evaluation in patients with chronic kidney disease-associated pruritus","volume":"84","author":"Vernon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.105_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100512","article-title":"Efficacy of difelikefalin for the treatment of moderate to severe pruritus in hemodialysis patients: pooled analysis of KALM-1 and KALM-2 phase 3 studies","volume":"4","author":"Topf","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.jaad.2026.08.105_bib14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2014.08.004","article-title":"Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis","volume":"71","author":"Ko","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.105_bib15","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.08.105_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamadermatol.2024.4796","article-title":"Efficacy and safety of nemolizumab in patients with moderate to severe prurigo nodularis: the olympia 1 randomized clinical phase 3 trial","volume":"161","author":"Stander","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.105_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(24)01203-0","article-title":"Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials","volume":"404","author":"Silverberg","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.08.105_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10157-021-02047-2","article-title":"Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study","volume":"25","author":"Kinugasa","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jaad.2026.08.105_bib19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ekir.2020.01.006","article-title":"Randomized controlled trial of difelikefalin for chronic pruritus in hemodialysis patients","volume":"5","author":"Fishbane","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jaad.2026.08.105_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A phase 3 trial of difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222603450X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222603450X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:27:42Z","timestamp":1793370462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222603450X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S019096222603450X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.105","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled study of nemolizumab in patients with chronic kidney disease-associated pruritus: NIKAIA-1","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}